Brown Capital Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
ACA
SCM
Brown Capital Management's KRYS Position: Q2 2026 in Review
Brown Capital Management increased its Krystal Biotech (KRYS) stake by 19% in Q2 2026, buying an estimated $514K and bringing the position to 10,968 shares worth $4.08M. The position accounts for 0.82% of the portfolio, ranked #37.
Brown Capital Management first reported a position in KRYS in Q1 2026 and has held it in 2 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.
- Brown Capital Management held 10,968 shares of Krystal Biotech worth $4.08M as of Q2 2026.
- Brown Capital Management bought 1,721 Krystal Biotech shares in Q2 2026, an estimated $514K.
- Krystal Biotech made up 0.82% of Brown Capital Management's portfolio in Q2 2026, its #37 holding.
- Brown Capital Management first reported a position in Krystal Biotech in Q1 2026 and has held it in 2 quarters since.
- 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.
Based on Brown Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.